Comprehensive Transcriptome Data to Identify Downstream Genes of Testosterone Signaling in Dermal Papilla Cells

November 2022 in “ Scientific Data ”

Himari Matsusaka, Tao Wu, Kai Furuya, Tomoe Yamada‐Kato, Lei Bai, Hiroshi Tomita, Eriko Sugano, Taku Ozaki, Tohru Kiyono, Isao Okunishi, T. Fukuda

testosterone dermal papilla cells androgenetic alopecia androgen receptor caveolin-1 dihydroxy testosterone DHT non-coding RNAs AGA AR

Studysummary This study identified downstream genes regulated by androgen receptor signaling in dermal papilla cells and suggests potential molecular targets for treating androgenetic alopecia and prostate cancer.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The study aimed to identify genes affected by testosterone signaling in dermal papilla cells (DPCs), which could help understand androgenetic alopecia (AGA). The researchers found that the androgen receptor (AR) is suppressed in human DPCs. After introducing AR into DPCs, they found that the expression of caveolin-1 is suppressed in AR-expressing DPCs, but recovers after dihydroxy testosterone (DHT) treatment. The study identified 27 downregulated genes and 130 upregulated genes as potential candidates for downstream genes of AR signaling pathways. The study also identified 168 differentially expressed non-coding RNAs, which could control gene expression. The data sets could be useful for studying the effect of AR signaling on prostate cancers and AGA.

View this study on nature.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Transcriptome Analysis to Identify the Downstream Genes of Androgen Receptor in Dermal Papilla Cells

1 citations , January 2022 in “BMC Genomic Data”

In this study, researchers found that androgen receptor activation in dermal papilla cells mainly affected the focal adhesion pathway and downregulated caveolin-1 gene expression, which could help identify new therapeutic targets for testosterone-related diseases.

Combinatorial Expression of Cell Cycle Regulators Is More Suitable for Immortalization Than Oncogenic Methods in Dermal Papilla Cells

research Combinatorial Expression of Cell Cycle Regulators Is More Suitable for Immortalization Than Oncogenic Methods in Dermal Papilla Cells

5 citations , January 2021 in “iScience”

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

research Human-Derived Immortalized Dermal Papilla Cells With Constant Expression of Androgen Receptor

8 citations , March 2020 in “Frontiers in Cell and Developmental Biology”

This study developed a DPC cell line by introducing mutant CDK4, Cyclin D1, and TERT, making it a promising tool to study downstream signaling pathways activated by testosterone in androgenetic alopecia.

research Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors

11 citations , December 2018 in “Assay and Drug Development Technologies”

This review highlights the challenges in screening for steroid 5 alpha-reductase inhibitors and discusses significant variability in the effectiveness of finasteride and dutasteride, calling for standardized testing methods to develop safer, more specific inhibitors from herbal preparations.

research Dihydrotestosterone-Inducible Dickkopf 1 from Balding Dermal Papilla Cells Causes Apoptosis in Follicular Keratinocytes

171 citations , July 2007 in “Journal of Investigative Dermatology”

The researchers reported that DHT-inducible DKK-1 may play a significant role in DHT-driven balding by inhibiting hair follicle cell growth and promoting apoptosis in androgenetic alopecia.